Navigation Links
Stemgent, CellDesign Sign Co-Exclusive Marketing Agreement on Stem Cell-Based Adipocyte Research Products
Date:3/24/2009

- Stemgent to provide CellDesign's proprietary adipocyte differentiation kits -

SAN DIEGO and NEW HAVEN, Conn., March 24 /PRNewswire/ -- Stemgent has signed a co-exclusive license to market CellDesign's AdipoDesign Starter Kit and AdipoDesign MaxiKit, which enable researchers to grow and study adipocytes from adipogenic progenitor cells. This agreement strengthens Stemgent's position as a provider of leading stem cell research technologies and enables CellDesign to take advantage of Stemgent's extensive reach into the stem cell research community.

The AdipoDesign Starter Kit and AdipoDesign Maxi Kit comprise committed human adipogenic progenitor cells as well as recovery, maintenance, and differentiation media, and allow the researcher to produce functional human adipocytes in two weeks. With applications in the fields of drug discovery, basic and applied research, toxicity testing, high throughput screens, and regenerative medicine, the study and use of adipocytes derived from these kits has the potential to have a significant impact.

Recent studies with Pfizer scientists have demonstrated that the AdipoDesign Kits produce mature adipocytes that exhibit physiologically relevant responses in a variety of predictive assays. The results from these studies were presented at StemCONN 09 on March 24, 2009 in New Haven, CT.

"Stemgent's commitment to stem cell research is unparalleled, and we anticipate that this relationship will hasten the introduction of CellDesign technologies into the academic market," commented John Hambor, CEO, CellDesign.

Added Ian Ratcliffe, CEO, Stemgent, "We are extremely excited to be able to offer CellDesign's cutting-edge technology for adipogenic progenitors to the stem cell research community."

Under the terms of the agreement, the kits will be sold under both companies' names. Kits will be shipped directly from Stemgent, and rep
'/>"/>

SOURCE Stemgent
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
6. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
7. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
8. Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug
9. Phlo Affiliate Names Director Of Marketing
10. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
11. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...y approved the Promega PowerPlex 16 HS System for ... DNA records for the National DNA Index System. ,...- The FBI recently approved the Promega PowerPlex...ipating in, or generating DNA records for, the Nat...ains more than seven million profiles and has assi...
(Date:11/24/2009)....24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V...fadvancedlasersystemsandinstrumentsforthestemcellr...ationalandfinancialresultsforthethirdquarterendedS...$1.46millioncomparedwith$1.43millioninQ32008,-Gros...inQ3,2008,-Netlossreducedto$148,000comparedto$283,...
(Date:11/24/2009)...irstCall/--ArenaPharmaceuticals,Inc.(Nasdaq: ARNA ...tatthePiperJaffray21stAnnualHealthCareConferenceon...icTime)attheNewYorkPalaceHotelinNewYorkCity.JackLi...heduledtoprovideanoverviewofthecompany,includingit...iveaudiowebcastofthepresentationwillbeavailableund...
(Date:11/24/2009).../--HealthRoboticstodayannounced,thatithasformedane...s.ThisrecentlyformedToronto-basedcompanywilloperat...et,install,andsupport,HealthRobotics,i.v.Roomofthe...tofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM)....onan"asneeded,basis"toitsstrategicpartnershipswith...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...Inc. (Nasdaq: NLTX ), today announced financial r... 2008., Net operating loss for the three months e...hare compared to $1.5 million or $0.11 per share, ...r the six months ended June,30, 2008 totaled $6.8 ...n,or $0.16 for the same period of 2007. Weighted a...
...e-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin ...eading Chinese firm specializing in the manufactur...n of probiotics products,today announced its finan...cal year, ended June 30, 2008., First Quarter 20...over-year to $11.4 million -- Gross profit increa...
...30 Investor Conference Call Scheduled fo... (OTC,Bulletin Board: SNKTY), a Life Sciences comp...t target the science of healthy aging, today annou...30, 2008., Revenue for the quarter ended June 30,...d in the second quarter of 2007., Net income for ...
Other Biology Technology:Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results 2Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results 3Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results 4China-Biotics, Inc. Reports First Quarter 2009 Financial Results 2China-Biotics, Inc. Reports First Quarter 2009 Financial Results 3China-Biotics, Inc. Reports First Quarter 2009 Financial Results 4China-Biotics, Inc. Reports First Quarter 2009 Financial Results 5China-Biotics, Inc. Reports First Quarter 2009 Financial Results 6China-Biotics, Inc. Reports First Quarter 2009 Financial Results 7China-Biotics, Inc. Reports First Quarter 2009 Financial Results 8China-Biotics, Inc. Reports First Quarter 2009 Financial Results 9China-Biotics, Inc. Reports First Quarter 2009 Financial Results 10China-Biotics, Inc. Reports First Quarter 2009 Financial Results 11Senetek PLC Reports Second Quarter 2008 Financial Results 2Senetek PLC Reports Second Quarter 2008 Financial Results 3
(Date:11/24/2009)...atomic-level action of a remarkable class of ring-...chers with the Lawrence Berkeley National Laborato... crystallography beamline at the Advanced Light So...s in gene expression and replication, and are vita... as infectious agents, such as the human papilloma...
(Date:11/24/2009)...t constitutes fish food is a matter of debate. A h...ish get almost 50 percent of their carbon from tre...een the terrestrial and aquatic ecosystems. , Bu...hows this is not likely to be true. Algae provide ..., according to research published this week in the...
(Date:11/23/2009)...ington, D.C. The community-associated strain of t...ia resistant to most common antibioticsposes a far...s making its way into hospitals, according to a st...Diseases . , The new threat is easily picked up...ces and has increased the overall burden of MRSA w...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Genome duplication responsible for more plant species than previously thought 9552 1Genome duplication responsible for more plant species than previously thought 9552 2Genome duplication responsible for more plant species than previously thought 9552 3New insights into limb formation 9549 1New insights into limb formation 9549 2Turners Utilization of BIM and Lean Construction on Middle Tennessee Medical Center in Murfreesboro Tenn to Save Project Millions of Dollars 54356 1Turners Utilization of BIM and Lean Construction on Middle Tennessee Medical Center in Murfreesboro Tenn to Save Project Millions of Dollars 54356 2
...a University Bloomington and eight collaborating i...ustaining community of bacteria that live in rocks...s weird? The bacteria rely on radioactive uranium ...he discovery is a confirmed expansion of Earth,s b...sses all planetary life. , The research has less...
... country in the world. Half the country is arid o...it. Natural resources are scarce. Yet 1.3 billio...rkable rate of economic growth. At the same time,...r shortages, water and air pollution, cropland and...mber issue of Frontiers in Ecology and the Environ...
...tions in flea carriers and mammal hosts, Pacific N...ered 176 proteins and likely proteins in the plag...d fall according to the disease’s virulence. , The...staff scientists Mary Lipton and Kim Hixson, ident...pecifically to growth condition,?according to a st...
Other Biology News:Bacteria that use radiated water as food 2Bacteria that use radiated water as food 3China's environmental challenges 2Plague proteome reveals proteins linked to infection 2
Mouse Anti-VEGF Receptor 1 Monoclonal Antibody, Unconjugated, Clone Flt-1 / EWC from Abcam
Anti-p14ARF / p16Beta Ab-1 Polyclonal Antibody, Unconjugated from Lab Vision
Mouse Anti-Human Gastric Carcinoma Marker [BY-1] Monoclonal Antibody, Unconjugated, Clone 3H11 from Santa Cruz Biotechnology, Inc.
Goat Anti-Human Dectin-1 / CLECSF12 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Biology Products: